RADNOR, Pa., May 06, 2018 -- Kaskela Law LLC announces that a shareholder class action lawsuit has been filed against Live Nation Entertainment, Inc. (NYSE:LYV) (“Live Nation” or the “Company”) on behalf of purchasers of the Company’s securities between February 23, 2017 and March 30, 2018, inclusive (the “Class Period”).
Live Nation investors are encouraged to visit www.kaskelalaw.com/case/live-nation-entertainment-inc/ to receive additional information about this action and submit their information online. Investors may also contact attorney D. Seamus Kaskela at (888) 715 – 1740, or via email at [email protected], to discuss their legal rights and options with respect to this action.
Live Nation produces live concerts and sells tickets to those events over the internet. The Company owns and operates over 195 venues throughout the world, and the Company significantly expanded its ticketing services with the purchase of Ticketmaster Entertainment (“Ticketmaster”) in 2010. In order to acquire Ticketmaster, Live Nation agreed to the terms of an antitrust consent decree with the Department of Justice (the “Consent Decree”). The Consent Decree contained specific rules to prevent the Company from monopolizing live music promotion and ticketing.
On April 1, 2018, after the close of the market, The New York Times published an article alleging that the Company had failed to abide by the terms of the Consent Decree aimed to prevent Live Nation from monopolizing the market for live musical performances. Following this news, shares of the Company’s stock fell $3.97 per share, or 9.4%, to close on April 2, 2018 at $38.17 per share.
The shareholder class action complaint alleges that Live Nation and certain of its senior executive officers made false and misleading statements and/or failed to disclose to investors that: (i) that the Company failed to abide by the terms of the Consent Decree; and (ii) the Company lacked adequate internal controls to prevent a violation of the Consent Decree. The complaint further alleges that, as a result of the foregoing, investors purchased Live Nation’s common stock at artificially inflated prices during the Class Period and sustained significant investment losses when the truth was revealed.
Investors who purchased Live Nation securities during the Class Period may, no later than June 18, 2018, seek to be appointed as a lead plaintiff representative of the class through Kaskela Law or other counsel, or may choose to do nothing and remain an absent class member. In order to be appointed as a lead plaintiff a class member must meet certain legal requirements.
Kaskela Law LLC exclusively prosecutes shareholder actions in state and federal courts throughout the country on behalf of investors. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.
CONTACT:
KASKELA LAW LLC
D. Seamus Kaskela, Esq.
201 King of Prussia Road
Suite 650
Radnor, PA 19087
(888) 715 – 1740
[email protected]
www.kaskelalaw.com


Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027
World game at war: why some European nations have threatened a World Cup boycott
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition
Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook
Qualcomm Stock Falls as Weak Q4 Forecast, Apple Revenue Decline Overshadow AI Data Center Growth
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 



